Nanjing AtomLife Co., Ltd. (referred to as “AtomLife") was established in 2018 and is located at Building 18, Phase II of LianDong U Valley in Jiangning, Nanjing. The company specializes in the research, development, production, promotion, and sales of high-end in vitro diagnostic products, dedicated to advancing the application of new testing technologies in the field of clinical testing. Currently, AtomLife has obtained 12 medical device registration certificates, forming a multi-series product line primarily based on flow fluorescence technology, with key application directions including cytokines and Alzheimer's disease. AtomLife adheres to the principle of "breaking through base-level technologies and targeting global markets," striving to become an internationally influential company in the field of life science technology and contributing to human health.